Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXAS1 | P24557 | 3/20 | 0.42 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | FABP4 | P15090 | 1/20 | 0.40 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.40 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.39 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.39 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.36 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | GABRP | O00591 | 1/20 | 0.36 |
| ▸ | GABRD | O14764 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5536326 | 0.94 | TBXAS1 (0.49) | TBXAS1FOLH1FABP4FABP5CYP19A1 | |
| Propionic Acid SCHEMBL28759037 | 0.93 | KDM4E (0.41) | TBXAS1FOLH1KDM4EFABP4FABP5 | |
| SCHEMBL5533757 | 0.93 | TBXAS1 (0.51) | TBXAS1FOLH1FABP4FABP5LMNA | |
| SCHEMBL5536313 | 0.93 | TBXAS1 (0.51) | TBXAS1FOLH1FABP4FABP5LMNA | |
| SCHEMBL5534333 | 0.93 | TBXAS1 (0.51) | TBXAS1FOLH1FABP4FABP5LMNA | |
| SCHEMBL5533488 | 0.93 | TBXAS1 (0.51) | TBXAS1FOLH1FABP4FABP5LMNA | |
| SCHEMBL5538144 | 0.93 | TBXAS1 (0.51) | TBXAS1FOLH1FABP4FABP5LMNA | |
| SCHEMBL5538968 | 0.93 | TBXAS1 (0.51) | TBXAS1FOLH1FABP4FABP5LMNA | |
| SCHEMBL5541468 | 0.93 | TBXAS1 (0.51) | TBXAS1FOLH1FABP4FABP5LMNA | |
| SCHEMBL5535357 | 0.93 | TBXAS1 (0.51) | TBXAS1FOLH1FABP4FABP5LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023039947-A1 | PHARMACEUTICAL COMPOSITION CONTAINING CEFOPERAZONE SODIUM AND TAZOBACTAM SODIUM AND APPLICATION THEREOF | 湘北威尔曼制药股份有限公司 | 2023-03-23 | — | — | WO | claimed |
| US-20220324770-A1 | NITRIFICATION INHIBITORS | THE UNIVERSITY OF MELBOURNE (AU) | 2022-10-13 | — | — | US | claimed |
| EP-4025564-A1 | NITRIFICATION INHIBITORS | The University of Melbourne (AU) | 2022-07-13 | — | — | EP | claimed |
| WO-2023039947-A1 | PHARMACEUTICAL COMPOSITION CONTAINING CEFOPERAZONE SODIUM AND TAZOBACTAM SODIUM AND APPLICATION THEREOF | 湘北威尔曼制药股份有限公司 | 2023-03-23 | — | — | WO | disclosed |
| US-20220324770-A1 | NITRIFICATION INHIBITORS | THE UNIVERSITY OF MELBOURNE (AU) | 2022-10-13 | — | — | US | disclosed |
| EP-4025564-A1 | NITRIFICATION INHIBITORS | The University of Melbourne (AU) | 2022-07-13 | — | — | EP | disclosed |
| US-20160083356-A1 | FUNCTIONALIZED 4- AND 5-VINYL SUBSTITUTED REGIOISOMERS OF 1, 2, 3-TRIAZOLES VIA 1, 3- DIPOLAR CYCLOADDITION AND POLYMERS THEREOF | ISP INVESTMENTS INC. (US) | 2016-03-24 | — | — | US | disclosed |
| US-20160083356-A1 | FUNCTIONALIZED 4- AND 5-VINYL SUBSTITUTED REGIOISOMERS OF 1, 2, 3-TRIAZOLES VIA 1, 3- DIPOLAR CYCLOADDITION AND POLYMERS THEREOF | ISP INVESTMENTS INC. (US) | 2016-03-24 | — | — | US | disclosed |
| US-20120041040-A1 | FUNCTIONALIZED 4- AND 5-VINYL SUBSTITUTED REGIOISOMERS OF 1, 2, 3-TRIAZOLES VIA 1, 3-DIPOLAR CYCLOADDITION AND POLYMERS THEREOF | ISP INVESTMENTS INC. (US) | 2012-02-16 | — | — | US | disclosed |
| US-20120041040-A1 | FUNCTIONALIZED 4- AND 5-VINYL SUBSTITUTED REGIOISOMERS OF 1, 2, 3-TRIAZOLES VIA 1, 3-DIPOLAR CYCLOADDITION AND POLYMERS THEREOF | ISP INVESTMENTS INC. (US) | 2012-02-16 | — | — | US | disclosed |
| US-20070284258-A1 | Method For Silver Plating | DAIWA FINE CHEMICALS CO., LTD. (JP) | 2007-12-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120041040-A1 | FUNCTIONALIZED 4- AND 5-VINYL SUBSTITUTED REGIOISOMERS OF 1, 2, 3-TRIAZOLES VIA 1, 3-DIPOLAR CYCLOADDITION AND POLYMERS THEREOF | ADH5, ADH1A, ADH1C | TBXAS1 556/4885FOLH1 4400/4885KDM4E 1072/4885 |
| US-20160083356-A1 | FUNCTIONALIZED 4- AND 5-VINYL SUBSTITUTED REGIOISOMERS OF 1, 2, 3-TRIAZOLES VIA 1, 3- DIPOLAR CYCLOADDITION AND POLYMERS THEREOF | ADH5, ADH1A, ADH1C | TBXAS1 556/4885FOLH1 4400/4885KDM4E 1072/4885 |
| US-20220324770-A1 | NITRIFICATION INHIBITORS | NOS1, NOS2, NIT2 | TBXAS1 2178/4885FOLH1 1621/4885KDM4E 2313/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.